newsfilter
← Latest News
GlobeNewswire·

Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

MIAMI, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory